EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

In vivo Pharmacokinetic Interactions Between Palbociclib and Rivaroxaban or Apixaban: Implications for Increased Drug Exposure and Dose Adjustments

Wenyu Du, Zihan Liu, Ying Li, Zhi Wang iD, Zhanjun Dong

Drug Design, Development and Therapy · 2025

DOI: 10.2147/dddt.s499209 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Wenyu Du und 4 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School, Hebei Medical University, Shijiazhuang, 050017, People's Republic of China. Hauptthemen laut MEDLINE: Pyridones, Pyrazoles, Pyridines, Piperazines. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyridonesPyrazolesPyridinesPiperazinesRivaroxabanFactor Xa InhibitorsAnimalsRats, Sprague-DawleyMaleRatsDrug InteractionsDose-Response Relationship, DrugAdministration, Oral

Stichwörter der Autor:innen

apixabancancer-associated venous thromboembolismdrug-drug interactionpalbociclibrivaroxaban

Substanzen

PyridonesapixabanPyrazolespalbociclibPyridinesPiperazinesRivaroxabanFactor Xa Inhibitors

Autor:innen und Institutionen

  • Graduate School, Hebei Medical University, Shijiazhuang, 050017, People's Republic of China.
  • Hebei General Hospital, Hebei Key Laboratory of Clinical Pharmacy, Shijiazhuang, 050051, People's Republic of China.

ORCID-Profile: Zhi Wang

Zitieren

APA

Du, W., Liu, Z., Li, Y., Wang, Z., & Dong, Z. (2025). In vivo Pharmacokinetic Interactions Between Palbociclib and Rivaroxaban or Apixaban: Implications for Increased Drug Exposure and Dose Adjustments. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s499209

Vancouver

Du W, Liu Z, Li Y, Wang Z, Dong Z. In vivo Pharmacokinetic Interactions Between Palbociclib and Rivaroxaban or Apixaban: Implications for Increased Drug Exposure and Dose Adjustments. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s499209

BibTeX
@article{Du2025,
  author = {Du, Wenyu and Liu, Zihan and Li, Ying and Wang, Zhi and Dong, Zhanjun},
  title = {In vivo Pharmacokinetic Interactions Between Palbociclib and Rivaroxaban or Apixaban: Implications for Increased Drug Exposure and Dose Adjustments},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  doi = {10.2147/dddt.s499209}
}
Kostenlos starten →